| Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma F Guillaumond, G Bidaut, M Ouaissi, S Servais, V Gouirand, O Olivares, ... Proceedings of the National Academy of Sciences 112 (8), 2473-2478, 2015 | 414 | 2015 |
| Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions O Olivares, JR Mayers, V Gouirand, ME Torrence, T Gicquel, L Borge, ... Nature communications 8 (1), 16031, 2017 | 402 | 2017 |
| Membrane cholesterol efflux drives tumor-associated macrophage reprogramming and tumor progression P Goossens, J Rodriguez-Vita, A Etzerodt, M Masse, O Rastoin, ... Cell metabolism 29 (6), 1376-1389. e4, 2019 | 371 | 2019 |
| Influence of the tumor microenvironment on cancer cells metabolic reprogramming V Gouirand, F Guillaumond, S Vasseur Frontiers in oncology 8, 117, 2018 | 136 | 2018 |
| Layilin augments integrin activation to promote antitumor immunity KM Mahuron, JM Moreau, JE Glasgow, DP Boda, ML Pauli, V Gouirand, ... Journal of Experimental Medicine 217 (9), 2020 | 49 | 2020 |
| Ketogenic HMG‐CoA lyase and its product β‐hydroxybutyrate promote pancreatic cancer progression V Gouirand, T Gicquel, EC Lien, E Jaune‐Pons, Q Da Costa, P Finetti, ... The EMBO journal 41 (9), e110466, 2022 | 46 | 2022 |
| Regulatory T cells promote innate inflammation after skin barrier breach via TGF-β activation JM Moreau, MO Dhariwala, V Gouirand, DP Boda, IC Boothby, MM Lowe, ... Science immunology 6 (62), eabg2329, 2021 | 38 | 2021 |
| Regulatory T cells and inflammatory mediators in autoimmune disease V Gouirand, I Habrylo, MD Rosenblum Journal of Investigative Dermatology 142 (3), 774-780, 2022 | 29 | 2022 |
| Regulatory T cells in skin mediate immune privilege of the hair follicle stem cell niche JN Cohen, V Gouirand, CE Macon, MM Lowe, IC Boothby, JM Moreau, ... Science immunology 9 (91), eadh0152, 2024 | 25 | 2024 |
| T-cell adhesion in healthy and inflamed skin JM Moreau, V Gouirand, MD Rosenblum JID innovations 1 (2), 100014, 2021 | 20 | 2021 |
| Fountain of youth of pancreatic cancer cells: the extracellular matrix V Gouirand, S Vasseur Cell Death Discovery 4 (1), 1, 2018 | 20 | 2018 |
| Layilin anchors regulatory T cells in skin P Mehta, V Gouirand, DP Boda, J Zhang, SV Gearty, B Zirak, MM Lowe, ... The Journal of Immunology 207 (7), 1763-1775, 2021 | 14 | 2021 |
| MTHFD2, metabolic mastermind of CD4+ T cell destiny V Gouirand, MD Rosenblum Science Immunology 7 (69), eabo6765, 2022 | 1 | 2022 |
| Tregs and inflammation—bring it on! V Gouirand, MD Rosenblum Science Immunology 6 (64), eabm5116, 2021 | 1 | 2021 |
| CD38 expression by neonatal human naïve CD4+ T cells shapes their distinct metabolic state and high regulatory T cell potential LR Dwyer, S Clancy, V Gouirand, C Chien, EE Rogers, SP Oltman, ... bioRxiv, 2025.01. 02.631038, 2025 | | 2025 |
| Layilin Regulates Treg Motility and Suppressive Capacity in Skin V Gouirand, S Clancy, C Macon, J Valle, M Pauli, HA Truong, J Cohen, ... bioRxiv, 2024.12. 30.630730, 2024 | | 2024 |
| 012 Tissue-specific manipulation of regulatory T cells reveals the skin to be a site of immune tolerance J Cohen, J Moreau, V Gouirand, C Macon, I Boothby, I Gratz, ... Journal of Investigative Dermatology 142 (8), S2, 2022 | | 2022 |
| Study of metabolic reprogramming during pancreatic cancer progression: Metabolism of branched chain amino acids V Gouirand, Q Da Costa, G Bidaut, S Beloribi-Djefaflia, T Gicquel, ... Pancreatology 17 (3), S114-S115, 2017 | | 2017 |
